Transthyretin Cardiac Amyloidosis Fellowship

    From Pfizer, Inc.

    The funder's mission is to improve outcomes for patients with advanced prostate cancer and to advance research, innovation, clinical expertise, and education for healthcare professionals in Latin America.

    Type of Support

    Overview

    This competitive grant program aims to enhance the training of healthcare professionals in recognizing and diagnosing ATTR cardiac amyloidosis. It supports institutions with fellowship programs for Cardiologists or Heart Failure Advanced Practice Providers. The focus is on strengthening clinical practice, research, and education related to ATTR cardiac amyloidosis.

    Eligibility

    Organization's Location
    fugiat pariatur
    Program Location
    irure
    Organization Type

    Submission

    Visit Apply for more information.